Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: BJU Int. 2016 May 20;118(5):677–680. doi: 10.1111/bju.13505

Table 1.

Rate ratio (RR*) of prostate cancer incidence and mortality per risk group and center.

low intermediate high metastatic total
NL RR incidence 2.93 1.71 1.05 0.42 1.98
RR mortality 4.49 1.46 0.87 0.38 0.83
BE RR incidence 1.21 1.18 0.98 0.96 1.16
RR mortality 0.59 0.98 1.68 0.65 0.86
SW RR incidence 2.31 0.94 0.81 0.50 1.55
RR mortality 3.00 0.64 0.67 0.45 0.61
FI RR incidence 1.70 0.99 0.93 0.71 1.27
RR mortality 1.71 1.29 1.17 0.62 0.90
IT RR incidence 1.59 1.62 0.94 0.77 1.38
RR mortality 1.13 0.99 1.09 0.58 0.90
SP RR incidence 2.69 1.41 1.38 0.31 1.76
RR mortality - - - 0.67 1.00
CH RR incidence 2.39 1.78 1.21 0.39 1.99
RR mortality 0.99 6.95 1.49 0.30 1.05
Total RR incidence 2.04 1.18 0.96 0.58 1.49
RR mortality 1.84 1.26 1.07 0.51 0.84

NL=the Netherlands, BE=Belgium, SW=Sweden, FI=Finland, IT=Italy, SP=Spain, CH=Switzerland.

RR incidence = rate ratio calculated as number of PCa detected / person years in the screening arm divided by the number of PCa detected / person years in the control arm.

RR mortality = rate ratio calculated as number of PCa deaths / person years in the screening arm divided by the number of PCa deaths / person years in the control arm.